Cargando…

Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing

More than 50 neurological and neuromuscular diseases are caused by short tandem repeat (STR) expansions, with 37 different genes implicated to date. We describe the use of programmable targeted long-read sequencing with Oxford Nanopore’s ReadUntil function for parallel genotyping of all known neurop...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevanovski, Igor, Chintalaphani, Sanjog R., Gamaarachchi, Hasindu, Ferguson, James M., Pineda, Sandy S., Scriba, Carolin K., Tchan, Michel, Fung, Victor, Ng, Karl, Cortese, Andrea, Houlden, Henry, Dobson-Stone, Carol, Fitzpatrick, Lauren, Halliday, Glenda, Ravenscroft, Gianina, Davis, Mark R., Laing, Nigel G., Fellner, Avi, Kennerson, Marina, Kumar, Kishore R., Deveson, Ira W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896783/
https://www.ncbi.nlm.nih.gov/pubmed/35245110
http://dx.doi.org/10.1126/sciadv.abm5386
Descripción
Sumario:More than 50 neurological and neuromuscular diseases are caused by short tandem repeat (STR) expansions, with 37 different genes implicated to date. We describe the use of programmable targeted long-read sequencing with Oxford Nanopore’s ReadUntil function for parallel genotyping of all known neuropathogenic STRs in a single assay. Our approach enables accurate, haplotype-resolved assembly and DNA methylation profiling of STR sites, from a list of predetermined candidates. This correctly diagnoses all individuals in a small cohort (n = 37) including patients with various neurogenetic diseases (n = 25). Targeted long-read sequencing solves large and complex STR expansions that confound established molecular tests and short-read sequencing and identifies noncanonical STR motif conformations and internal sequence interruptions. We observe a diversity of STR alleles of known and unknown pathogenicity, suggesting that long-read sequencing will redefine the genetic landscape of repeat disorders. Last, we show how the inclusion of pharmacogenomic genes as secondary ReadUntil targets can further inform patient care.